Polypeptide Library Normalization via Unnatural Amino Acid Incorporation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for screening polypeptide libraries, especially those containing unnatural amino acids, face challenges in maintaining library diversity due to differential expression rates, leading to desirable variants being underrepresented or lost.
Innovation Solution
The development of novel compositions and methods for normalizing expression levels in polypeptide libraries by incorporating unnatural amino acids into both screenable and packaging polypeptides, ensuring all variants face equal growth disadvantages, thereby maintaining library diversity and enabling the detection of variants with enhanced properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If polypeptide variants comprising unnatural amino acids are screened using conventional methods, then variants with enhanced or novel properties can be identified, but library diversity is lost due to differential expression rates causing desirable variants to become underrepresented or lost
Solution Approach 1:
The patent changes the expression parameter by incorporating unnatural amino acids into both the screenable polypeptide and the packaging polypeptide. This parameter change equalizes the expression levels of all library members by imposing a uniform growth disadvantage, thereby preventing differential expression from causing diversity loss while still enabling detection of functional variants
Solution Approach 2:
The patent creates equipotential expression conditions by ensuring all polypeptide variants in the library incorporate the same unnatural amino acid into the packaging polypeptide. This equalizes the growth burden across all variants, preventing any single variant from gaining a selective advantage and thus maintaining library diversity throughout the screening process
2Productivity
If repeated cycles of screening, isolation, and amplification are performed, then functional variants can be enriched, but highly expressed variants become over-represented due to growth advantages rather than functional superiority
Solution Approach 1:
The patent modifies the expression parameter by incorporating unnatural amino acids into the packaging polypeptide, which creates a uniform growth disadvantage for all variants. This parameter change ensures that enrichment during repeated screening cycles reflects true functional superiority rather than differential expression rates, allowing desirable variants to be correctly identified and enriched
3Manufacturing precision
If polypeptide variants with unnatural amino acids are expressed in vivo, then site-specific incorporation of unnatural amino acids with unique functional groups is achieved, but expression bias occurs favoring proteins containing only natural amino acids
Solution Approach 1:
The patent changes the expression parameter by incorporating the same unnatural amino acid into both the screenable polypeptide and the packaging polypeptide at site-specific positions. This dual incorporation strategy maintains the site-specific precision benefit while equalizing expression levels by imposing a uniform growth disadvantage on all library members, thereby eliminating the expression bias against variants containing unnatural amino acids
Data Source
AI summary
The invention provides methods and compositions for screening polypeptide libraries that include variants comprising unnatural amino acids. In addition, the invention provides vector packaging systems and methods for packaging a nucleic acid in a vector. Compositions of vectors produced by the methods and systems are also provided.